K Pharma,Inc.
4896.T · JPX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | ¥7 | ¥8 | ¥9 | ¥11 |
| - Cash | ¥2 | ¥3 | ¥1 | ¥0 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥5 | ¥5 | ¥7 | ¥11 |
| Revenue | ¥0 | ¥1 | ¥0 | ¥0 |
| % Growth | -100% | – | – | – |
| Gross Profit | ¥0 | ¥1 | ¥0 | -¥0 |
| % Margin | – | 91% | – | – |
| EBITDA | -¥1 | ¥0 | -¥0 | -¥0 |
| % Margin | – | 36.6% | – | – |
| Net Income | -¥1 | ¥0 | -¥0 | -¥0 |
| % Margin | – | 26% | – | – |
| EPS Diluted | -72.94 | 22.43 | -42.06 | -19.79 |
| % Growth | -425.2% | 153.3% | -112.5% | – |
| Operating Cash Flow | -¥1 | ¥0 | -¥0 | -¥0 |
| Capital Expenditures | -¥0 | -¥0 | -¥0 | ¥0 |
| Free Cash Flow | -¥1 | ¥0 | -¥0 | -¥0 |